Navigation Links
US Patent Allowed for NOD Tech
Date:11/24/2009

SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. announced the US Patent & Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology.

NOD technology is a highly efficient approach to incorporate peptides or proteins into bio-adhesive nano-particles to enable oral delivery of drugs otherwise administered as injections. NOD technology is a platform technology that can be applied to many macromolecular drugs such as insulin, interferon, growth hormone, exenatide, heparin and more.

Currently, an oral insulin formulation, the first candidate developed with NOD technology, is entering phase I clinical studies in China.

"Patent allowance for NOD technology is a major step forward for NOD", quoted from William Lee, CEO. "With this patent, and in combination with others, NOD is building a solid foundation for its intellectual property and core competence."

    For more information, please contact:

     William Lee, Ph.D., CEO
     Phone: +86-21-6194-0758
     Email: info@nodpharm.com


    Notes for Editors

About NOD Pharmaceuticals

NOD Pharmaceuticals, Inc. is a development stage biotech company and emerging leader in innovative delivery for biopharmaceuticals. NOD uses patented platform technology, nano-particle oral delivery or NOD technology, to develop oral formulations for biopharmaceuticals, including insulin, exenatide, interferon, human growth hormone and more.

More information can be found at http://www.nodpharm.com .

SOURCE NOD Pharmaceuticals, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
2. BioLife Solutions Granted Japanese Biopreservation Patent
3. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
4. AvidBiotics Corp. Granted Key U.S. and European Patents on Unique Protein Modification Platform
5. Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
6. Celsis IVT Granted U.S. Patent for LiverPool(TM) Hepatocytes
7. Athera Receives Allowance of Two Key Patents
8. Jeremy M. Stipkala to Lead Symposium Entitled Patent Law Developments at SERMACS 2009
9. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
10. ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System
11. Martek Announces Settlement of Patent Dispute with Capsugel France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... (PRWEB) October 02, 2014 ... throughput research solutions for biopharmaceutical development, today announced ... - 24, 2014 at GlaxoSmithKline (GSK) in Ware, ... discussions of best practices in high throughput research ... R&D leaders gathered together to discuss the challenges ...
(Date:10/2/2014)... 02, 2014 At a time when many ... has introduced a new kind of squeeze aimed at ... the Scienceware® Squeeze Rite™ Wash Bottle , catalog no. ... within the bottle reduces the waste of reagents, solutions and ... liquids. , “Easier to squeeze when compared to standard 500ml ...
(Date:10/2/2014)... 2, 2014 SIRO Clinpharm, an ... at the prestigious Annual Conference of the Society for ... Vegas , where they were invited to speak ... like ,data analytics to support fraud detection, ,clinical data ... ,benefits of working together as virtual and integrated teams,. ...
(Date:10/1/2014)... Switzerland (PRWEB) October 01, 2014 ... the quality of the final product. However, while ... regulated, regulatory frameworks such as Good Manufacturing Practices ... the responsibility of the manufacturer to interpret these ... consistent weighing performance quality. METTLER TOLEDO experts have ...
Breaking Biology Technology:Freeslate European Summit Highlights Best Practices in High Throughput Research and Data Management 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas 2Comply with Weighing-Related Regulations in Pharma Manufacturing 2
... Aug. 28 Medivation, Inc.,(Nasdaq: MDVN ) today ... will present at the following conferences:, -- BioCentury,s ... 9:00 a.m. Eastern Time at the Millennium Broadway Hotel ... Conference on Wednesday, September 24,at 4:30 p.m. Eastern Time ...
... Exclusion of Venous Thromboembolism-, LEXINGTON, Mass., Aug. ... US Food and Drug Administration (FDA) has,granted 510(k) ... HemosIL D-Dimer,assay to exclude venous thromboembolism (VTE) in ... embolism (PE), when used in,conjunction with a clinical ...
... (ESA) has appointed the UK,s National Physical Laboratory (NPL) ... will lead a consortium to identify the next generation ... in future space missions. , "Advances in nanotechnology are ... Research Scientist in the nanomaterials group at NPL, who ...
Cached Biology Technology:Medivation Announces Participation in Upcoming Conferences 2Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay 2
(Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
(Date:9/30/2014)... Prenatal exposure to tetrachloroethylene (PCE) in drinking water ... abruption, according to a new study led by ... , The study, published in the journal ... 1,019 unexposed pregnancies among 1,766 women in Cape ... late 1960s to the early 1980s by the ...
(Date:9/30/2014)... runoff in Hawaii is causing tumors in endangered sea ... published Tuesday in the peer-reviewed open-access journal PeerJ ... in algae that the turtles eat, promoting the formation ... organs. , Scientists at Duke University, the University of ... conducted the study to better understand the causes ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Contaminated water linked to pregnancy complications, BU study finds 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... Autism Speaks applauds the consensus statement and recommendations ... disorders in children with autism spectrum disorders (ASD) released ... advancing physician awareness of unique challenges in the medical ... see the publication of these consensus recommendations. Autism Speaks, ...
... nerves are the likely origin of the Devil Facial Tumour ... an international team of scientists has discovered. Devil ... only Tasmanian devils and was first reported in 1996. It ... disease is characterised by large tumours, mostly on the face ...
... have new insight into the sex lives of the much-maligned ... deaths, according to a report published online on December 31st ... finding a partner of the right species type, male and ... harmony. Those tones are produced and varied based on the ...
Cached Biology News:Pediatrics GI recommendations -- first step to guidelines for children with autism 2Pediatrics GI recommendations -- first step to guidelines for children with autism 3Nervous culprit found for Tassie devil facial tumor disease 2To a mosquito, matchmaking means 'singing' in perfect harmony 2
Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: New Recommended Storage: Long term: -20C; Short term: +4...
X box-binding protein 1...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
Biology Products: